SynthesisFrontiers in immunology2021

KL-6 as an Immunological Biomarker Predicts the Severity, Progression, Acute Exacerbation, and Poor Outcomes of Interstitial Lung Disease: A Systematic Review and Meta-Analysis.

Tao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.